Synergy of CTL tumor cytotoxicity with myxoma oncolytic virotherapy

被引:0
|
作者
Chen, Meixuan [1 ]
Matos, Ana L. [1 ]
Yuvaraj, Padhmavathy [1 ]
Belmont, Laura [1 ]
McFadden, Grant [1 ]
Anderson, Karen S. [1 ]
机构
[1] Arizona State Univ, Biodesign Inst, Tempe, AZ USA
关键词
D O I
10.1158/1538-7445.AM2019-4093
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4093
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Oncolytic Virotherapy with Myxoma Virus
    Rahman, Masmudur M.
    McFadden, Grant
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [2] Ex Vivo Virotherapy with Oncolytic Myxoma Virus
    McFadden, Grant
    Rahman, Masmudur
    Chan, Winnie
    Villa, Nancy
    Cogle, Christopher R.
    HUMAN GENE THERAPY, 2014, 25 (12) : A4 - A4
  • [3] Oncolytic Virotherapy and the Tumor Microenvironment
    Berkey, Sara E.
    Thorne, Steve H.
    Bartlett, David L.
    TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : 157 - 172
  • [4] Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells
    Stanford, Marianne M.
    Barrett, John W.
    Nazarian, Steven H.
    Werden, Steven
    McFadden, Grant
    JOURNAL OF VIROLOGY, 2007, 81 (03) : 1251 - 1260
  • [5] Mathematical model of oncolytic virotherapy with Myxoma virus infection in cancer cells
    Ortegon, Sofia
    Franco, Lina
    McFadden, Grant
    Cordovez, Juan
    FASEB JOURNAL, 2020, 34
  • [6] Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin
    Lun, Xue Qing
    Zhou, Hongyuan
    Alain, Tommy
    Sun, Beichen
    Wang, Limei
    Barrett, John W.
    Stanford, Marianne M.
    McFadden, Grant
    Bell, John
    Senger, Donna L.
    Forsyth, Peter A.
    CANCER RESEARCH, 2007, 67 (18) : 8818 - 8827
  • [7] Transforming the prostatic tumor microenvironment with oncolytic virotherapy
    Atherton, Matthew J.
    Stephenson, Kyle B.
    Tzelepis, Fanny
    Bakhshinyan, David
    Nikota, Jake K.
    Son, Hwan Hee
    Jirovec, Anna
    Lefebvre, Charles
    Dvorkin-Gheva, Anna
    Ashkar, Ali A.
    Wan, Yonghong
    Stojdl, David F.
    Belanger, Eric C.
    Breau, Rodney H.
    Bell, John C.
    Saad, Fred
    Singh, Sheila K.
    Diallo, Jean-Simone
    Lichty, Brian D.
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [8] Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
    Enow, Junior A.
    Sheikh, Hummad I.
    Rahman, Masmudur M.
    VIRUSES-BASEL, 2023, 15 (11):
  • [9] Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer
    Stanford, Marianne M.
    McFadden, Grant
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (09) : 1415 - 1425
  • [10] TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy
    Valenzuela-Cardenas, Miriam
    Gowan, Cody
    Dryja, Parker
    Bartee, Mee Y.
    Bartee, Eric
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)